These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6719469)

  • 1. Cystamine modulation of galactosamine-induced hepatotoxicity.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicol Appl Pharmacol; 1984 May; 73(3):551-8. PubMed ID: 6719469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicol Appl Pharmacol; 1985 Oct; 81(1):17-24. PubMed ID: 4049417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of galactosamine cytotoxicity in an in vivo/in vitro hepatocellular toxicity model.
    MacDonald JR; Thayer KJ; White C
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):269-77. PubMed ID: 3603561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystamine treatment of chemically induced liver injury.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Dev Toxicol Environ Sci; 1983; 11():463-6. PubMed ID: 6677487
    [No Abstract]   [Full Text] [Related]  

  • 5. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
    Schiessel C; Forsthove C; Keppler D
    Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of protective effect of D-003, a mixture of high-molecular-weight primary acids from sugar cane wax, on liver damage induced by galactosamine in rats.
    Noa M; Mendoza S; Mas R; Mendoza N
    J Med Food; 2005; 8(3):343-7. PubMed ID: 16176145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximide.
    Koff RS; Connelly LJ
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):519-22. PubMed ID: 1257252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Drug Chem Toxicol; 1985; 8(6):483-94. PubMed ID: 4092620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of galactosamine-induced liver injury by some amino acids or Triton WR1339.
    de Ferreyra EC; de Fenos OM; Castro JA
    Toxicol Lett; 1983 Apr; 16(1-2):63-7. PubMed ID: 6836615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells.
    Stachlewitz RF; Seabra V; Bradford B; Bradham CA; Rusyn I; Germolec D; Thurman RG
    Hepatology; 1999 Mar; 29(3):737-45. PubMed ID: 10051475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
    Keegan-Rogers V; Wu GY
    Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
    Perrissoud D; Maignan MF; Dumont JM
    Liver; 1985 Apr; 5(2):55-63. PubMed ID: 3999934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of carbon tetrachloride-induced hepatic necrosis by post-toxicant treatment with cystamine.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicology; 1986 May; 39(2):135-48. PubMed ID: 3705080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological studies on schizandra fruits. III. Effects of wuweizisu C, a lignan component of schizandra fruits, on experimental liver injuries in rats].
    Takeda S; Funo S; Iizuka A; Kase Y; Arai I; Ohkura Y; Sudo K; Kiuchi N; Yoshida C; Maeda S
    Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):193-208. PubMed ID: 2989131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteryl hemisuccinate treatment protects rodents from the toxic effects of acetaminophen, adriamycin, carbon tetrachloride, chloroform and galactosamine.
    Fariss MW; Lippman HR; Mumaw VR; Ray SD
    Toxicol Lett; 1997 Feb; 90(2-3):133-44. PubMed ID: 9067481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensification of galactosamine hepatotoxicity by polyriboinosinic acid-polyribocytidylic acid.
    Sakakibara S; Namba N; Shiomi K; Kagamiyama H
    Life Sci; 1985 Feb; 36(8):705-12. PubMed ID: 3974407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by pantethine, pantothenic acid and cystamine against carbon tetrachloride-induced hepatotoxicity in the rat.
    Nagiel-Ostaszewski I; Lau-Cam CA
    Res Commun Chem Pathol Pharmacol; 1990 Feb; 67(2):289-92. PubMed ID: 2333416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats.
    Gujral JS; Farhood A; Jaeschke H
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):37-46. PubMed ID: 12831781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of zinc on liver injury induced by D-galactosamine in rats.
    Hu HL; Chen RD; Ma LH
    Biol Trace Elem Res; 1992 Jul; 34(1):27-33. PubMed ID: 1382519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats.
    Wang F; Wen T; Chen XY; Wu H
    Inflamm Res; 2008 Apr; 57(4):183-8. PubMed ID: 18344059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.